Neurol. pro Praxi, 2005; 5: 251-254

Komorbidita pri Parkinsonovej chorobe

doc. MUDr. Ján Benetin PhD
II. neurologická klinika LF UK FNsP akademika L. Dérera v Bratislave

U pacientov s Parkinsonovou chorobou (PCH) je viacero faktorov, ktoré môžu vplývať na komorbiditu. Niekedy nie je jednoznačne možné odlíšiť či k novým príznakom alebo ochoreniu viedla samotná progresia ochorenia, vplyv antiparkinsonskej liečby, alebo náhodná koincidencia iného ochorenia. Zväčša sa na ťažkostiach pacienta podieľajú všetky tejto vplyvy. V článku sa popisujú najčastejšie sa vyskytujúce ochorenia u pacientov s idiopatickou Parkinsonovou chorobou a ťažkosti, ktoré môžu výraznejšie ovplyvňovať kvalitu života a možnosti liečby týchto pacientov.

Keywords: Kľúčové slová: Parkinsonova choroba, komorbidita, cerebrovaskulárne ochorenia, psychiatrické ochorenia, traumy.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Benetin J. Komorbidita pri Parkinsonovej chorobe. Neurol. praxi. 2005;6(5):251-254.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001; 248: 950-958. Go to original source... Go to PubMed...
    2. Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2004 Dec 9; 351 (24): 2509-2518. Go to original source... Go to PubMed...
    3. Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson's disease Journal of Neurology Neurosurgery and Psychiatry 2003; 74: 163-169. Go to original source... Go to PubMed...
    4. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Saturiano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol 2001; 54: 661-674. Go to original source... Go to PubMed...
    5. Horner S, Niederkorn K, Ni XS, Fischer R, Fazekas F, Schmidt R, Duft M, Augustin M, Homann N, Ott E. Evaluation of vascular risk factors in patients with Parkinson syndrome Nervenarzt. 1997 dec; 68 (12): 967-971.
    6. Jellinger KA.Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathol (Berl). Epub 2003 Feb 19, 105 (5): 415-419. Go to original source... Go to PubMed...
    7. Korten A, Lodder J, Vreeling F, Boreas A, van Raak L, Kessels F. Related Articles, Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke? Mov Disord. 2001 Jan; 16 (1): 119-123. Go to original source... Go to PubMed...
    8. Levine RL, Jones JC, Bee N. Stroke and Parkinson's disease. Stroke. 1992 Jun; 23 (6): 839-842. Go to original source... Go to PubMed...
    9. Martignoni E, Godi L, Citterio A, Zangaglia R, Riboldazzi G, Calandrella D, Pacchetti C, Nappi G; Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. Neurol Sci. 2004 Jun; 25 (2): 66-71. Go to original source... Go to PubMed...
    10. Nuti A, Ceravolo R, Piccinni A, Dell'Agnello G, Bellini G, Gambaccini G, Rossi C, Logi C, Dell'Osso L, Bonuccelli U. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol. 2004 May; 11 (5): 315-20. Go to original source... Go to PubMed...
    11. Papapetropoulos S, Ellul J, Argyriou AA, Talelli P, Chroni E, Papetropoulos T. The effect of vascular disease on late onset Parkinson's disease Eur J.Neurol. 2004 Apr; 11 (4): 231-235. Go to original source... Go to PubMed...
    12. Rektor I, Rektorová I. Parkinsonova nemoc a příbuzná onemocnění v praxi. Triton 1999, 152 s.
    13. Rektorová I. Kognitivní a behaviorální poruchy u demence při Parkinsonově nemoci a u demence s Lewyho tělísky. Neurologia pre prax. 1/2004: 25-28.
    14. Růžička E, Roth J, Kaňovský P. Parkinsonova nemoc a parkinsonské syndromy. Praha, Galén 2001. 293 s.
    15. Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom J. Cholinergic dysfunction in diseases with Lewy bodies. Neurology. 2000 Jan 25; 54 (2): 407-411. Go to original source... Go to PubMed...
    16. Valkovic P, Benetin J, Blazicek P, Valkovicova L, Gmitterova K, Kukumberg P. Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients. Parkinsonism and Related Disorders 11 (2005): 253-256. Go to original source... Go to PubMed...
    17. Zesiewicz TA, Strom JA, Borenstein AR, Hauser RA, Cimino CR, Fontanet HL, Cintron GB, Staffetti JF, Dunne PB, Sullivan KL. Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey. Parkinsonism Relat Disord. 2004 Oct; 10 (7): 417-420. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.